Journalist Hunt

Journalist DatabaseFor JournalistsPricing
LoginSign up

Stanton R. Mehr - Journalist Profile | Connect with top journalists

View 's journalist industries, journalist types, location, and media outlets. Use Journalist Hunt to get connected with top journalists in seconds.

Get connected with journalists today
Principal, Biosimilars Review & Report

Stanton R. Mehr

Verified

Principal, Biosimilars Review & Report

Philadelphia

Beats

Primary beats

Health

Secondary beats

Mental health awarenessCrimePC GamingWomen in STEMConventions and conferencesPersonal GrowthMental HealthHealthcareEntertainmentOutdoorsPublic Health InitiativesFamily fun and activitiesFilm and TVShowbizEnvironment and educationWomen Empowerment

Biography

Final Covers

Space , Animals, Health , Biology, Environment, Science

Doesn’t Cover

Journalist Type

other journalists

Seniority Positions

Principal

Industries

Content

Total articles 172

  • Available on paid plans

    Biosimilar Bytes: Eculizumab Biosimilar Launches, Rights to Actemra Biosimilar Sold, and New Biosimilar Bevacizumab Approved

    By Stanton R. Mehr

    Apr. 10, 2025

  • Available on paid plans

    Biosimilar Hearings Day in Congress

    By Stanton R. Mehr

    Apr. 09, 2025

  • Available on paid plans

    Biosimilar Bytes: Eculizumab Biosimilar Launches, Rights to Actemra Biosimilar Sold, and New Biosimilar Bevacizumab Approved

    By Stanton R. Mehr

    Apr. 10, 2025

As seen in

Springer,American Journal Of Managed Care,Life Science Leader,Pharmaceutical Executive,Bioprocess Online,Biosimilars Review & Report,Biosimilar Development,Onclive

Company Info

Biosimilars Review & Report

Biosimilars Review & Report (BR&R) provides education, commentary, and updates on the US biosimilar marketplace, including a free, updated database on all 351(k) biologic licensing applications to the FDA.

, ,

Founded: 2014